Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
Mariam Jafri, Naomi C Wake, David B Ascher, Douglas EV Pires, Dean Gentle, Mark R Morris, Eleanor Rattenberry, Michael A Simpson, Richard C Trembath, Astrid Weber, Emma R Woodward, Alan Donaldson, Tom L Blundell, Farida Latif, Eamonn R Maher
CANCER DISCOVERY | AMER ASSOC CANCER RESEARCH | Published : 2015
M. Jafri is in receipt of a Medical Research Council Clinical Research Fellowship. D.B. Ascher is supported by a National Health and Medical Research Council CJ Martin Fellowship. D.E.V. Pires is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil. M.A. Simpson thanks the National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London for financial support. E.R. Maher thanks the Association for International Cancer Research (AICR; now Worldwide Cancer Research), The Eveson Charitable Trust, and the NIHR Biomedical Research Centre based at Cambridge for financial support.